GO:1902533 positive regulation of intracellular signal transduction: Signaling Amplification, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1902533 describes any process that increases the frequency, rate, or extent of intracellular signal transduction, a core biological process that amplifies and propagates signals from receptors to downstream effectors.
• This term encompasses activation of intracellular signaling cascades, including kinase cascades, second messenger systems, and protein-protein interactions that relay signals.
• Dysregulation of positive regulation of intracellular signal transduction is implicated in cardiac hypertrophy, cancer, and metabolic disorders [1,5].
• Key genes involved include MAPK1, AKT1, PIK3CA, and YAP1, which are frequently studied using CRISPR knockout, knock-in, and overexpression models [1,6].
• Experimental methods such as phosphoproteomics, live-cell imaging, and CRISPR library screening are essential to dissect these pathways [2,5].
• EDITGENE provides comprehensive CRISPR services to model positive regulation of intracellular signal transduction in disease and development.
Description
Intracellular signal transduction is the process by which cells convert extracellular or intracellular cues into specific cellular responses. Positive regulation of intracellular signal transduction (GO:1902533) refers to any process that activates or increases the frequency, rate, or extent of this signaling, ensuring robust and timely cellular reactions. This regulation is critical for normal physiology, including cardiac growth, immune responses, and metabolic homeostasis [1,2]. Dysregulation of these positive regulatory mechanisms underlies numerous pathologies, such as cancer, cardiac hypertrophy, and neurodegenerative disorders [1,5]. Understanding the molecular players and mechanisms of GO:1902533 is therefore essential for both basic research and therapeutic development. Researchers increasingly rely on CRISPR-based models to dissect these pathways, enabling precise genetic perturbations.
positive regulation of intracellular signal transduction At A Glance
| GO ID | GO:1902533 |
|---|---|
| GO term | positive regulation of intracellular signal transduction |
| Ontology | biological_process |
| Synonym | activation of intracellular signaling cascade; positive regulation of intracellular signaling pathway; upregulation of intracellular signal transduction |
| Major function | Amplification and propagation of intracellular signals, leading to cellular responses such as proliferation, differentiation, and survival [1,2] |
| Related processes | Intracellular signal transduction (GO:0035556), regulation of intracellular signal transduction (GO:1902531) |
| Disease relevance | Cardiac hypertrophy, cancer, metabolic disorders [1,5] |
| Experimental approaches | CRISPR knockout, knock-in, overexpression, phosphoproteomics, live-cell imaging [2,6] |
What Is GO:1902533?
GO:1902533, positive regulation of intracellular signal transduction, is defined as any process that activates or increases the frequency, rate, or extent of intracellular signal transduction. This includes the activation of intracellular signaling cascades, such as kinase cascades, second messenger pathways, and other signaling events that occur within the cell to propagate a signal from a receptor or sensor to downstream effectors [1,2].
Why Is positive regulation of intracellular signal transduction Important in Cell Biology?
Positive regulation of intracellular signal transduction is fundamental to how cells sense and respond to their environment. It ensures that signals are amplified and transmitted with fidelity, controlling processes such as gene expression, metabolism, and cell fate decisions. Aberrant positive regulation can lead to diseases like cancer, where hyperactive signaling drives uncontrolled proliferation, or cardiac hypertrophy, where excessive signaling leads to heart failure [1,5]. Thus, understanding the mechanisms and components of GO:1902533 is crucial for identifying therapeutic targets and developing precision medicine strategies.
• Controls cell proliferation, differentiation, and survival through kinase cascades.
• Essential for cardiac hypertrophy and heart failure pathogenesis.
• Implicated in cancer progression via oncogenic signaling pathways.
• Regulates metabolic homeostasis, including glycolysis and ATP production.
• Involved in bone homeostasis through YAP subcellular localization.
• Modulates immune responses and inflammation via cytokine signaling.
• Target for therapeutic intervention in multiple diseases [1,5].
• Provides mechanistic insights into signal amplification and feedback loops.
• Enables synthetic biology approaches to engineer signaling circuits.
• Facilitates drug discovery through identification of novel modulators.
What Happens During positive regulation of intracellular signal transduction?
Receptor Activation and Signal Initiation
In simple terms: A signal molecule binds to a receptor, turning it on.
Positive regulation often begins with the activation of cell surface receptors, such as G protein-coupled receptors or receptor tyrosine kinases, by ligands. This activation triggers conformational changes that enable the receptor to interact with intracellular signaling proteins. For example, in cardiac hypertrophy, neurohormonal factors activate receptors that initiate intracellular cascades.
Amplification via Kinase Cascades
In simple terms: A series of kinases activate each other, amplifying the signal.
Once initiated, signals are amplified through sequential phosphorylation events in kinase cascades, such as the MAPK/ERK pathway. Each kinase activates multiple downstream kinases, leading to exponential signal amplification [1,2]. This ensures a robust cellular response even to weak initial stimuli.
Second Messenger Generation
In simple terms: Small molecules like cAMP or calcium spread the signal inside the cell.
Positive regulation also involves the production of second messengers, such as cyclic AMP (cAMP), calcium ions, or inositol triphosphate (IP3). These molecules diffuse within the cell and activate downstream effectors, further propagating the signal. In cytokinin signaling, second messengers modulate cell division.
Protein-Protein Interactions and Scaffolding
In simple terms: Proteins come together to pass the signal along efficiently.
Scaffold proteins bring together components of signaling pathways, enhancing specificity and efficiency. For instance, the ESCRT machinery coordinates ubiquitin signaling and autophagy, which are linked to intracellular signal transduction [7,8]. These interactions ensure that positive regulation is tightly controlled.
Feedback and Crosstalk
In simple terms: The signal can be adjusted by feedback loops and interactions with other pathways.
Positive regulation is balanced by negative feedback mechanisms to prevent excessive signaling. Crosstalk between pathways, such as between MAPK and PI3K/AKT, allows integration of multiple signals [1,5]. Dysregulation of these feedback loops can lead to pathological states.
Key Genes Involved in GO:1902533 positive regulation of intracellular signal transduction
The following genes and proteins are key players in positive regulation of intracellular signal transduction, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MAPK1 | Kinase in MAPK cascade; amplifies signals from receptors to nucleus | Frequently mutated in cancers; target for knockout studies |
| AKT1 | Serine/threonine kinase; promotes cell survival and growth | Oncogene; studied via knock-in and overexpression |
| PIK3CA | Catalytic subunit of PI3K; generates PIP3 second messenger | Mutated in many cancers; CRISPR models available |
| YAP1 | Transcriptional co-activator; responds to Hippo signaling | Regulates bone homeostasis; knockout models exist |
| MTOR | Kinase; central regulator of cell growth and metabolism | Target of rapamycin; studied in longevity pathways |
| EGFR | Receptor tyrosine kinase; initiates signaling cascades | Overexpressed in cancers; knockout and knock-in models |
| SRC | Non-receptor tyrosine kinase; propagates signals | Involved in cancer and bone biology |
| RAS | Small GTPase; activates MAPK and PI3K pathways | Mutated in cancers; point mutation models |
| CALM1 | Calmodulin; mediates calcium signaling | Regulates cardiac hypertrophy; knockout models |
| PRKACA | Catalytic subunit of PKA; phosphorylates downstream targets | Involved in metabolic regulation; knockout studies |
| GSK3B | Kinase; regulates glycogen metabolism and signaling | Implicated in neurodegeneration; knockout models |
| TSC1 | Tumor suppressor; inhibits mTOR signaling | Knockout leads to mTOR hyperactivation |
| TSC2 | Tumor suppressor; partners with TSC1 | Mutations cause tuberous sclerosis; CRISPR models |
| PTEN | Phosphatase; antagonizes PI3K signaling | Tumor suppressor; knockout models for cancer |
| NFKB1 | Transcription factor; mediates immune and inflammatory signaling | Knockout models for inflammation studies |
| STAT3 | Transcription factor; transduces cytokine signals | Oncogene; overexpression and knockout models |
| RAP1 | Small GTPase; regulates cell adhesion and signaling | Studied in bone homeostasis; knockout models |
How Is positive regulation of intracellular signal transduction Regulated?
Positive regulation of intracellular signal transduction is itself tightly regulated by various mechanisms. Negative feedback loops, such as those involving phosphatases (e.g., PTEN) and inhibitors (e.g., TSC1/TSC2), prevent excessive signaling [4,5]. Additionally, post-translational modifications like ubiquitination and phosphorylation control the stability and activity of signaling components [7,8]. Crosstalk between pathways, such as mTOR and AMPK, integrates nutrient and energy status to modulate signal transduction. Dysregulation of these regulatory mechanisms can lead to diseases like cancer and cardiac hypertrophy [1,5].
positive regulation of intracellular signal transduction and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MAPK1 | Cancer, cardiac hypertrophy | Knockout and point mutation models in cell lines |
| PIK3CA | Cancer | Knock-in of activating mutations; overexpression |
| YAP1 | Bone homeostasis | Knockout and tagged knock-in for localization |
| MTOR | Metabolic disorders, aging | Knockout and overexpression in mammalian cells |
| PTEN | Cancer | Knockout models to study PI3K hyperactivation |
Cardiac Hypertrophy and Heart Failure
Positive regulation of intracellular signal transduction is central to the development of cardiac hypertrophy. Neurohormonal activation triggers kinase cascades, including MAPK and PI3K/AKT, leading to increased protein synthesis and cell growth in cardiomyocytes. While initially compensatory, sustained hyperactivation results in heart failure. Targeting these signaling pathways is a therapeutic strategy.
Cancer
Many cancers harbor mutations that constitutively activate intracellular signaling pathways, such as PI3K/AKT/mTOR and MAPK. These mutations enhance positive regulation, driving uncontrolled proliferation and survival. For example, alpha-enolase influences ATP pool and lactate homeostasis in gastric cancer, linking metabolism to signaling. CRISPR screens have identified numerous regulators of these pathways as potential drug targets.
Metabolic Disorders
Dysregulated intracellular signal transduction contributes to metabolic diseases like diabetes and obesity. Insulin signaling, which involves positive regulation of PI3K/AKT, is impaired in insulin resistance. Mitochondrial longevity pathways also intersect with signal transduction, affecting aging and metabolism.
Bone Homeostasis
Snhg18 regulates Yap subcellular localization to maintain bone homeostasis, highlighting the role of Hippo signaling in skeletal health. Disruption of positive regulation can lead to bone disorders, making it a target for therapeutic intervention.
From positive regulation of intracellular signal transduction-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X positively regulate MAPK signaling? | CRISPR knockout of gene X followed by phospho-ERK Western blot |
| What is the effect of a point mutation in kinase Y on signal transduction? | Point mutation knock-in using CRISPR |
| How does overexpression of gene Z affect pathway activity? | CRISPR-mediated overexpression (e.g., CRISPRa) |
| Where is protein A localized during signaling? | Tagged knock-in with fluorescent protein |
| Which genes are essential for signal transduction? | Genome-wide CRISPR library screening |
| Does a disease-associated SNP alter signaling? | Knock-in of SNP using CRISPR |
How to Study the positive regulation of intracellular signal transduction Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Phosphoproteomics | Global phosphorylation changes | Identify kinase substrates and pathway activation |
| Live-cell imaging | Protein localization and dynamics | Study real-time signaling events |
| CRISPR library screening | Gene essentiality and pathway regulators | Discover novel modulators of signal transduction |
| RNA-seq | Transcriptional changes | Assess downstream gene expression |
| Western blot | Protein expression and phosphorylation | Validate specific signaling events |
| Co-immunoprecipitation | Protein-protein interactions | Map signaling complexes |
| Flow cytometry | Cell phenotype and signaling status | Quantify pathway activation in single cells |
| CRISPR knockout | Gene function loss | Determine causal role in signaling |
Phosphoproteomics
Phosphoproteomics allows global analysis of phosphorylation events, providing a snapshot of kinase activity and signaling networks. This method is crucial for identifying substrates and quantifying changes in positive regulation of intracellular signal transduction [1,5].
Live-Cell Imaging
Live-cell imaging with fluorescently tagged proteins (e.g., via CRISPR knock-in) enables real-time visualization of signaling dynamics, including translocation and interactions. This technique has been used to study YAP subcellular localization in bone homeostasis.
CRISPR Library Screening
Genome-wide CRISPR knockout or activation screens identify genes that positively or negatively regulate signaling pathways. These screens are powerful for discovering novel regulators and drug targets.
RNA Sequencing (RNA-seq)
RNA-seq measures transcriptional changes downstream of signaling activation, revealing gene expression programs controlled by positive regulation. It is often combined with CRISPR perturbations to link genotype to phenotype [2,5].
How CRISPR Can Be Used to Study GO:1902533 positive regulation of intracellular signal transduction
Knockout
CRISPR knockout is used to completely ablate a gene of interest to determine its necessity in positive regulation of intracellular signal transduction. For example, knocking out MAPK1 can reveal its role in cardiac hypertrophy. This approach is straightforward and widely applicable.
Point Mutation
Point mutation knock-in via CRISPR allows the introduction of specific disease-associated or functional mutations. This is critical for studying how single amino acid changes affect signaling, such as activating mutations in PIK3CA.
Knock-in
Knock-in of reporter tags (e.g., GFP) or epitope tags enables visualization and purification of signaling proteins. Tagged knock-in of YAP1 has been used to track its subcellular localization in bone homeostasis.
Overexpression
CRISPR activation (CRISPRa) or traditional overexpression vectors can increase gene expression to study gain-of-function effects. Overexpressing AKT1 can enhance survival signaling, mimicking oncogenic states.
How EDITGENE Supports positive regulation of intracellular signal transduction Research
Researchers studying positive regulation of intracellular signal transduction-related genes often need to determine whether a candidate gene is causally involved in signaling, and how mutations or expression changes affect pathway activity. EDITGENE provides a comprehensive suite of CRISPR services to enable such investigations with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of intracellular signal transduction research.
Frequently Asked Questions About positive regulation of intracellular signal transduction
What is GO:1902533?
GO:1902533 is the Gene Ontology term for positive regulation of intracellular signal transduction, describing any process that activates or increases the frequency, rate, or extent of intracellular signal transduction.
What genes are involved in positive regulation of intracellular signal transduction?
Key genes include MAPK1, AKT1, PIK3CA, YAP1, MTOR, and many others that encode kinases, phosphatases, and scaffold proteins [1,5,6].
How is positive regulation of intracellular signal transduction studied?
Common methods include CRISPR knockout, knock-in, overexpression, phosphoproteomics, live-cell imaging, and CRISPR library screening [2,5,6].
Why is positive regulation of intracellular signal transduction important?
It controls fundamental cellular processes like proliferation, differentiation, and survival, and its dysregulation leads to diseases such as cancer and cardiac hypertrophy [1,5].
What diseases are associated with GO:1902533?
Diseases include cancer, cardiac hypertrophy, metabolic disorders, and bone diseases [1,5,6].
What are the synonyms for GO:1902533?
Synonyms include activation of intracellular signaling cascade, positive regulation of intracellular signaling pathway, and upregulation of intracellular signal transduction.
How does CRISPR help study positive regulation of intracellular signal transduction?
CRISPR enables precise genetic perturbations such as knockout, knock-in, and overexpression to determine gene function in signaling pathways [5,6].
What is the role of MAPK1 in intracellular signal transduction?
MAPK1 is a kinase in the MAPK cascade that amplifies signals from receptors to the nucleus, regulating gene expression.
Can EDITGENE create custom knockout models for signaling genes?
Yes, EDITGENE provides custom CRISPR knockout cell models for any gene involved in intracellular signal transduction.
What is the difference between positive and negative regulation of intracellular signal transduction?
Positive regulation activates or increases signaling, while negative regulation inhibits or decreases it; both are essential for balanced cellular responses.
Conclusion
Positive regulation of intracellular signal transduction (GO:1902533) is a fundamental biological process that ensures robust and precise cellular responses to signals. Its dysregulation is implicated in numerous diseases, making it a prime target for research and therapeutic intervention. Advances in CRISPR technology and functional genomics have revolutionized our ability to dissect these pathways. EDITGENE stands ready to support researchers with state-of-the-art CRISPR models and services to unravel the complexities of intracellular signal transduction.
References
- 1. Nakamura M et al.. 2018. Mechanisms of physiological and pathological cardiac hypertrophy.. Nat Rev Cardiol 15(7):387-407 PMID: 29674714
- 2. Yang W et al.. 2021. Molecular mechanism of cytokinin-activated cell division in Arabidopsis.. Science 371(6536):1350-1355 PMID: 33632892
- 4. Vendelbo MH et al.. 2011. Mitochondrial longevity pathways.. Biochim Biophys Acta 1813(4):634-44 PMID: 21295080
- 5. Shu X et al.. 2025. Alpha-enolase influences ATP pool of cytoplasm and lactate homeostasis by regulating glycolysis in gastric cancer.. Signal Transduct Target Ther 10(1):356 PMID: 41168198
- 6. Huang J et al.. 2025. Snhg18 regulates Yap subcellular localization to maintain bone homeostasis.. Nat Commun 16(1):7543 PMID: 40813368
- 7. Roxrud I et al.. 2010. ESCRT & Co.. Biol Cell 102(5):293-318 PMID: 20222872
- 8. Grumati P et al.. 2018. Ubiquitin signaling and autophagy.. J Biol Chem 293(15):5404-5413 PMID: 29187595
